NDC: 68151-5204-0 1 TABLET in a PACKAGE
Inform patients to take ELIPHOS® with meals, adhere to their prescribed diets, and avoid the use of calcium supplements including nonprescription antacids. Inform the patients about the symptoms of hypercalcemia [see Warnings and Precautions (5.1) and Adverse Reactions (6.1)].
Advise patients who are taking an oral medication where reduction in the bioavailability of that medication would have clinically significant effect on its safety or efficacy to take the drug one hour before or three hours after ELIPHOS®.
Hawthorn Pharmaceuticals, Inc.
Morristown, NJ 07960
Calcium AcetateLabel Image
| ELIPHOS |
calcium acetate tablet
|Labeler — Carilion Materials Management (079239644)|
|Carilion Materials Management||079239644||REPACK (68151-5204)|
Revised: 08/2016 Carilion Materials Management
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.